A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

859

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Bacterial Conjunctivitis
Interventions
DRUG

Gatifloxacin 0.5% eye drops

Day 1 = 1 drop of study medication every 2hrs up to 8 times total; day 2-5 = 1 drop twice daily

DRUG

placebo eye drops

Day 1 = 1 drop of study medication every 2hrs up to 8 times total; day 2-5 = 1 drop twice daily

Trial Locations (2)

Unknown

Downey

RajajiNagar

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY